The Cigna Group vs Oscar Health, Inc., two Managed Care stocks. A side-by-side on valuation, growth, margins, returns, and what each price is betting.
The margin lines cross in an odd place: Oscar Health posts the better operating margin, 15.2% against Cigna's 3.4%, yet nets out negative while Cigna keeps 2.3%, the gap between an individual-market insurer still below its cost of capital and a diversified giant that long ago made peace with thin. Cigna trades at 12 times earnings with a 2.1% dividend; Oscar has no multiple to quote. Both free-cash figures, 11.8% and 28.5%, are float first and yield second. Cigna's 14.8% return on equity against Oscar's negative 2.4% completes the maturity portrait. The pair prices insurance as an institution against insurance as a startup, and the institution currently costs less per dollar of everything.
Comparison updated 2026-07-10.
| Metric | CI | OSCR |
|---|---|---|
| Price | $282.39 | $29.79 |
| Market cap | $74.6B | $9.8B |
| Sector | Managed Care | Managed Care |
| Stage | Mature | Growth |
| P/E | 12.0 | — |
| P/B | 1.76 | 5.89 |
| P/S | 0.27 | 0.74 |
| EV/EBITDA | 5.6 | 309.2 |
| Revenue growth | +8.9% | +30.5% |
| Operating margin | 3.4% | 15.2% |
| Net margin | 2.3% | -0.3% |
| Return on equity | 14.8% | -2.4% |
| Return on assets | 4.1% | -0.4% |
| Return on invested capital | 17.9% | 0.5% |
| FCF yield | 11.8% | 28.5% |
| Dividend yield | 2.1% | — |
| Debt / equity | 0.04 | 0.26 |
| Current ratio | 0.82 | 1.09 |
| Altman Z (solvency) | 2.64 | 2.14 |
| Piotroski F (quality) | 6 / 9 | 8 / 9 |
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
The stronger value is highlighted per metric where one is strictly better on that single number; it is not an overall verdict on either company. For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.